LUND-HANSEN TORBEN enters Y-MABS THERAPEUTICS, INC. with 45.66K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 9/20/2018ACC: 0001104659-18-057854
Officer· Sr. VP and Head of Tech Op
Since Sep 2018
45.66K
Baseline shares
0.00
Direct ownership
0 positions
150K
Derivative underlying
1 instrument
1
Security positions
45.66K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned45.66K
Total
45.66K indirect45.66K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 45.66K | Indirect |
| Total | 45.66K | 45.66K indirect |
Derivative Holdings1
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
N/A
Exercise price
4.38
Expiration
—
Exercise window
—
Total
Underlying
150K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 4.38 | — | — | 150K | N/A |
| Total | 150K | 0.00 | ||||